Everyone diagnosed with a rare cancer should have effective treatments and a chance to live.
Consented intake · your records travel with you · nothing moves without your sign-off
A nonprofit advancing more effective, personalized treatments for rare cancers through research funding, expert collaboration, and patient support since 2009. Patients can access the TCF-001 TRACK trial (a remote precision-medicine trial you can enroll in from home), rare-cancer education, and connection to experts and community.
Prefer the source? TargetCancer Foundation's own site has more.
The fastest way to know what you'll pay: check your coverage with your plan. Below is what we know about how TargetCancer Foundation handles billing.
We don't have confirmed insurance details for TargetCancer Foundation yet. Start a coverage check with your plan, or contact the provider directly.
Answers grounded in TargetCancer's details here. Educational only; your oncologist directs treatment.
Ask OpenCancer · answers grounded in this storefront
Other providers in similar categories.
Have a place to make all of my data accessible for analysis and make it easy to share. Improve capture of patient-reported data regarding treatments.
Gather distinctive biomarkers that can guide treatment and monitor disease progression
FoundationOne CDx is an FDA-approved comprehensive genomic profiling test that analyzes 324 genes to identify clinically relevant genomic alterations.
Tempus xT is a comprehensive genomic profiling test combining DNA and RNA sequencing to identify actionable mutations.
This page is general information. Upload your records for analysis specific to YOUR diagnosis.